Medtronic is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity. The MiniMedTM 780G system was presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Florence, Italy. Results showed users achieved a TITR of greater than 56% with the use of recommended optimal settings, outperforming international targets of 70% TIR.